详细家族史对识别高危黑色素瘤患者的重要性
该回顾性研究纳入1995年至2017年在格罗宁根大学医学中心监测项目的224名成人,按家族史和遗传评估分层。中位随访5.6年,38人(17.0%)诊断61个黑色素瘤,总体风险显著高于一般人群(SIR 73)。风险组4的黑色素瘤发生率与风险组2相当(aHR 1.27,p=0.576),提示符合「可能家族性黑色素瘤」标准者也应考虑监测。
要点
- 详细家族史可分层识别黑色素瘤高危个体。
- 符合「可能家族性黑色素瘤」标准者风险与家族性黑色素瘤相当。
- 现行荷兰指南不再推荐监测该群体,但研究支持考虑监测。
核心结论
- 按家族史分层可识别黑色素瘤高危个体。
- 符合「可能家族性黑色素瘤」标准者应考虑监测,与荷兰推荐相反。
研究设计与样本
- 共224名参与者,平均年龄44.7岁,56.7%为女性。
- 按遗传评估和家族史分为风险组0-5,比较黑色素瘤发生率。
主要发现
- 中位随访5.6年(IQR 3.7-7.8),38名(17.0%)参与者诊断61个黑色素瘤。
- 总体黑色素瘤风险显著高于一般人群(SIR 73)。
- 风险组4的黑色素瘤发生率与风险组2相当(aHR 1.27,p=0.576)。
临床怎么用
- 临床中应详细采集黑色素瘤家族史以进行风险分层。
- 对符合「可能家族性黑色素瘤」标准者,可考虑纳入监测。
局限性
- 回顾性设计可能引入偏倚。
- 样本量较小(224名),结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is essential to identify individuals with the highest risk of developing melanoma and to withhold individuals from surveillance with a low risk. However, international consensus on surveillance indications and the role of family history is still lacking. OBJECTIVES: To provide more insight into the association between a family history of melanoma and the risk of developing melanoma. METHODS: Adults who participated in the surveillance programme of the University Medical Center Groningen between June 1995 and November 2017 were retrospectively included. Participants were stratified into risk groups according to genetic assessment and family history following current Dutch guidelines: hereditary melanoma (risk group 1), familial melanoma (risk group 2) and their first-degree relatives (risk group 3), and other screening reasons (risk group 0). We included individuals fulfilling the 'possible familial melanoma' criteria (risk group 4) and their first-degree relatives (risk group 5), as evolving Dutch guidelines no longer recommend to screen these individuals. Melanoma incidence during follow-up was compared with the general population using standardized incidence ratios (SIRs), and the rate of developing melanomas was compared between risk groups and expressed as adjusted hazard ratios (aHRs). RESULTS: In total, 224 participants were included (mean age 44.7 years; 56.7% female). During a median follow-up of 5.6 years (IQR, 3.7-7.8), a total number of 61 melanomas were diagnosed among 38 (17.0%) participants. The overall melanoma risk was significantly higher than in the general population (SIR 73). The rate of developing melanoma in risk group 4 was comparable to risk group 2 (aHR 1.27, p = 0.576). CONCLUSIONS: Stratification of individuals according to their family history of melanoma identifies those with a high risk of developing melanoma. Contrary to Dutch recommendations, surveillance should also be considered for melanoma patients fulfilling the 'possible familial melanoma' criteria.
引用
- Jansen MR, El Moumni M, van Leeuwen BL, et al. Identifying high-risk melanoma patients: The importance of acquiring a detailed family history. J Eur Acad Dermatol Venereol. 2025. PMID: 40035439. doi:10.1111/jdv.20601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。